Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauri E Markowitz

Showing results (101-110 of 290) with videos related to

Pageof 29
Sort By:
International Journal of Cancer|February 20, 2013
Can clinical tests help monitor human papillomavirus vaccine impact?Elissa Meites, Carol Lin, Elizabeth R Unger, et al.
Vaccine|March 2, 2010
Post-licensure monitoring of HPV vaccine in the United StatesLauri E Markowitz, Susan Hariri, Elizabeth R Unger, et al.
Journal of American College Health : J of ACH|April 9, 2005
Sexually transmitted disease services at US colleges and universitiesEmilia H Koumans, Maya R Sternberg, Cathy Motamed, et al.
Sexually Transmitted Diseases|July 11, 2007
The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive healthEmilia H Koumans, Maya Sternberg, Carol Bruce, et al.
Vaccine|August 8, 2012
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United StatesHarrell W Chesson, Donatus U Ekwueme, Mona Saraiya, et al.
MMWR. Morbidity and Mortality Weekly Report|August 23, 2019
Human Papillomavirus-Attributable Cancers - United States, 2012-2016Virginia Senkomago, S Jane Henley, Cheryll C Thomas, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 18, 2015
Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010Emiko Y Petrosky, Susan Hariri, Lauri E Markowitz, et al.
Journal of the American Dental Association (1939)|August 2, 2011
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistryJennifer L Cleveland, Michele L Junger, Mona Saraiya, et al.
Annals of Internal Medicine|December 10, 2019
Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Sexually Transmitted Diseases|August 5, 2003
The syphilis reactor grid: help or hindrance for syphilis surveillance?Catherine A McLean, Katrin Kohl, Meghan A Baker, et al.
Pageof 29

Showing results (101-110 of 290) with videos related to

Sort By:
Pageof 29
International Journal of Cancer|February 20, 2013
Can clinical tests help monitor human papillomavirus vaccine impact?Elissa Meites, Carol Lin, Elizabeth R Unger, et al.
Vaccine|March 2, 2010
Post-licensure monitoring of HPV vaccine in the United StatesLauri E Markowitz, Susan Hariri, Elizabeth R Unger, et al.
Journal of American College Health : J of ACH|April 9, 2005
Sexually transmitted disease services at US colleges and universitiesEmilia H Koumans, Maya R Sternberg, Cathy Motamed, et al.
Sexually Transmitted Diseases|July 11, 2007
The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive healthEmilia H Koumans, Maya Sternberg, Carol Bruce, et al.
Vaccine|August 8, 2012
Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United StatesHarrell W Chesson, Donatus U Ekwueme, Mona Saraiya, et al.
MMWR. Morbidity and Mortality Weekly Report|August 23, 2019
Human Papillomavirus-Attributable Cancers - United States, 2012-2016Virginia Senkomago, S Jane Henley, Cheryll C Thomas, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 18, 2015
Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010Emiko Y Petrosky, Susan Hariri, Lauri E Markowitz, et al.
Journal of the American Dental Association (1939)|August 2, 2011
The connection between human papillomavirus and oropharyngeal squamous cell carcinomas in the United States: implications for dentistryJennifer L Cleveland, Michele L Junger, Mona Saraiya, et al.
Annals of Internal Medicine|December 10, 2019
Effectiveness and Cost-Effectiveness of Human Papillomavirus Vaccination Through Age 45 Years in the United StatesJean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Sexually Transmitted Diseases|August 5, 2003
The syphilis reactor grid: help or hindrance for syphilis surveillance?Catherine A McLean, Katrin Kohl, Meghan A Baker, et al.
Pageof 29